Lanplus 30 mg (Capsule (Enteric Coated))
Unit Price: ৳ 10.00 (5 x 6: ৳ 300.00)
Strip Price: ৳ 60.00
Medicine Details
Category | Details |
---|---|
Generic | Dexlansoprazole |
Company | Radiant pharmaceuticals ltd |
Also available as |
Indications
- Healing of Erosive Esophagitis
- Maintenance of Healed Erosive Esophagitis
- Symptomatic Non-Erosive Gastroesophageal Reflux Disease
Pharmacology
- Proton Pump Inhibitor (PPI)
- Gastric acid secretion suppression
- Specific inhibition of (H⁺/K⁺)-ATPase
- Dual Delayed Release (DDR) formulation
- Plasma concentration-time profile with two distinct peaks
Dosage
- 30 mg Once daily for Maintenance of Healed erosive esophagitis and relief of heartburn
- 30 mg Once daily for Symptomatic Non-Erosive GERD
- 60 mg Once daily for Healing of erosive esophagitis
- 30 mg tablet once daily for 6 months in adults and 16 weeks in patients 12 to 17 years of age
- Granules should not be chewed
Administration
- Can be taken without regard to food
- Swallowed whole
- Alternatively administered by sprinkling intact granules on one tablespoon and swallowing immediately
- Missed capsule should be taken as soon as possible or only the prescribed dose taken at the appointed time
Interaction
- With medicine: Atazanavir, Warfarin, Tacrolimus, Clopidogrel & Methotrexate. With food & others: No data available
Contraindications
- Hypersensitivity to any component of the formulation
Side Effects
- Diarrhea
- Abdominal pain
- Nausea
- Vomiting
- Flatulence
Pregnancy & Lactation
- Pregnancy Category B
- No adequate and well-controlled studies with Dexlansoprazole in pregnant women
- No adequate and well-controlled studies with Dexlansoprazole in Lactating mother
Precautions & Warnings
- Gastric Malignancy
- Clostridium difficile Associated Diarrhea
- Bone fracture
- Hypomagnesemia
- Concomitant use with Methotrexate
Use in Special Populations
- Safety and effectiveness not established in patients below 12 years age
- No dose adjustment for elderly patients
- No dose adjustment for renal impairment
- No dose adjustment for patients with mild hepatic impairment
- Consider maximum daily dose of 30 mg for patients with moderate hepatic impairment
Overdose Effects
- No reports of significant overdose
- Multiple doses of 120 mg and a single dose of 300 mg did not result in severe adverse events
Therapeutic Class
- Proton Pump Inhibitor
Storage Conditions
- Store below 30°C temperature
- Store in a dry place protected from light
- Keep all medicines out of reach of children
Related Brands
- Dexilend 30 mg (Capsule (Enteric Coated)) - ziska-pharmaceuticals-ltd
- Dexilend 60 mg (Capsule (Enteric Coated)) - ziska-pharmaceuticals-ltd
- Dexlan 30 mg (Capsule (Enteric Coated)) - ibn-sina-pharmaceuticals-ltd
- Dexlan 60 mg (Capsule (Enteric Coated)) - ibn-sina-pharmaceuticals-ltd
- Desopra 30 mg (Capsule (Enteric Coated)) - alco-pharma-ltd